Myriad Genetics, Inc.

MYGN Healthcare Diagnostics & Research

Myriad Genetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $824.5 million, down 1.56% from fiscal 2024. In the quarter to June 2026, revenue fell 10.5%, EPS grew 87.1%, free cash flow grew 43.9% and total debt rose 103.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.98 0.37 −8.51%
Market cap
$416.1M
P/E
0.0×
Fwd P/E
−6.0×
Dividend yield
—
F-score
5/9
Altman Z
−1.52
Beneish M
−5.42
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
0.82 0.69 0.51 0.67
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
31.90 53.73 (26.86) (65.22)
P/B ratio
1.81 1.55 1.25 1.78
Price to Tangible BV
4.26 3.49 2.92 4.60
EV/Sales
0.86 0.73 0.58 0.75
EV/EBITDA
0.00 0.00 0.00 0.00
EV/Operating CF
(321.19) 332.88 198.73 78.73
EV/FCF
(18.45) (23.41) (20.56) (42.69)
Quick Ratio
1.78 1.98 1.91 1.72
Current Ratio
2.33 2.49 2.40 2.21
Net Debt/EBITDA
2.42 (3.09) 0.32 (0.21)
Debt/Assets
16.41% 16.97% 17.86% 18.89%
Debt/Equity
0.32 0.33 0.36 0.40
Asset Turnover
0.91 0.95 0.99 1.23
Operating CF/Net income
(0.77) (1.34) 0.46 0.19
Capex/Depreciation
(0.49) (0.39) (0.36) (0.26)
Interest Coverage
(6.13) (1.30) (7.49) (9.49)
Research and Development Expense of Revenue
13.71% 12.15% 13.52% 13.11%
Selling, General and Administrative Expense of Revenue
67.53% 59.25% 67.76% 73.89%
Intangible Assets out of Total Assets
0.29 0.29 0.29 0.29
Share Based Compensation of Revenue
5.93% 1.33% 3.24% 3.78%
Graham Net Nets
(0.02) (0.01) (0.06) (0.08)
Graham Number
0.00 0.00 0.00 0.00
Earnings Yield
(59.90%) (64.08%) (95.56%) (20.84%)
Free Cash Flow Yield
(5.69%) (4.50%) (5.50%) (2.62%)
Revenue per Share
2.21 2.27 2.14 2.01
Operating CF per Share
0.23 0.11 (0.17) (0.09)
Capex per Share
(0.07) (0.06) (0.07) (0.03)
Free Cash Flow per Share
0.16 0.05 (0.24) (0.12)
Cash per Share
1.56 1.62 1.33 1.22
Shareholders Equity per Share
4.00 3.97 3.60 3.21
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
4.00 3.97 3.60 3.21
Free Cash Flow
14.90 4.60 (22.20) (11.50)
Working Capital
196.80 198.80 182.60 158.30
Capital Expenditures
(6.20) (6.00) (6.50) (3.20)
Net Current Asset Value
(10.50) (6.00) (23.50) (46.00)
EV/EBIT
0.00 0.00 0.00 0.00
Capex to Sales
0.03 0.03 0.03 0.02
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Receivables
121.85 118.25 122.10 123.25
Average Payables
30.70 31.15 30.35 30.65
Average Inventory
28.90 29.05 28.10 29.65
Average Assets
904.70 867.10 839.90 658.10
Average Common Equity
552.25 534.55 521.15 346.00

Fold the line items

Columns are period end dates